Quantitative analysis of an impact of P-glycoprotein on edoxaban's disposition using a human physiologically based pharmacokinetic (PBPK) model.
Int J Pharm. 2021 Mar 15;597:120349. doi: 10.1016/j.ijpharm.2021.120349. Epub 2021 Feb 2.
Int J Pharm. 2021.
PMID: 33545293